News
A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to ...
The prevalence of irritable bowel syndrome and constipation rose significantly during the COVID-19 pandemic, highlighting the ...
When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.
FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.
1d
HealthDay on MSN2023 to 2024 COVID-19 Vaccine Provided Additional EffectivenessThe 2023 to 2024 COVID-19 vaccine provided additional effectiveness against medically attended COVID-19, according to a study published online June 24 in JAMA Network Open. Ruth Link-Gelles, Ph.D., M.
FITBOOK magazine on MSN1d
Razor-Like Throat Pain May Indicate New Coronavirus VariantSharp throat pain that feels like swallowing razor blades—this symptom is particularly noticeable in infections with the new ...
The firm is seeking marketing clearance for its Liaison NES real-time PCR instrument along with a multiplex test for flu A/B, COVID-19, and respiratory syncytial virus infection.
In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.
The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results